找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Cell Therapy; Yasuo Ikeda (Professor),Jun-ichi Hata (Professor), Conference proceedings 2000 Springer-Verlag Tokyo 2000 Carcinom.Vivo.bone

[復(fù)制鏈接]
樓主: 令人不愉快
11#
發(fā)表于 2025-3-23 13:32:31 | 只看該作者
12#
發(fā)表于 2025-3-23 17:03:10 | 只看該作者
A Novel Acute Promyelocytic Leukemia Model: From Cell to Murine System patients achieve complete remission by the treatment of all-. RA; however, clinical remissions are usually of brief duration, and these patients often develop RA-resistant disease. The mechanisms of RA resistance in APL cells are poorly understood, and most clinical approaches have not been success
13#
發(fā)表于 2025-3-23 18:59:42 | 只看該作者
Phase 1 Trial of Retroviral-Mediated Transfer of the Human MDR-1 in Patients Undergoing High-Dose Ch-sensitive drugs such as the vinca alkaloids, anthracyclines, podophyllotoxins, and taxanes. In this report of a phase 1 clinical study performed at the Columbia-Presbyterian Medical Center, we demonstrate the safety and efficacy of transfer of the human multiple drug resistance (MDR) gene into hema
14#
發(fā)表于 2025-3-24 01:44:25 | 只看該作者
Basic Studies Toward Hematopoietic Stem Cell Gene Therapyare an ideal target for gene therapy. Retroviral vectors are predominantly used for transduction of HSCs, but the gene transfer efficiency is extremely low. Several efforts have been made at achieving clinically relevant gene transfer efficiencies. First, new cytokines such as Flt-3 ligand and throm
15#
發(fā)表于 2025-3-24 03:30:09 | 只看該作者
Ex Vivo Expansion of Hematopoietic Cells neutropenia following transplantation. To date, no clinical studies using ex vivo expanded cells have demonstrated any decrease in the time to neutrophil or platelet recovery, although a number of clinical studies have been performed using a variety of growth factor cocktails and culture conditions
16#
發(fā)表于 2025-3-24 10:15:56 | 只看該作者
17#
發(fā)表于 2025-3-24 13:02:40 | 只看該作者
18#
發(fā)表于 2025-3-24 17:28:30 | 只看該作者
19#
發(fā)表于 2025-3-24 22:44:56 | 只看該作者
20#
發(fā)表于 2025-3-25 01:38:55 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-11 12:06
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
淮北市| 碌曲县| 聂荣县| 岳池县| 镇巴县| 马尔康县| 莫力| 南溪县| 大余县| 宣武区| 新疆| 宜城市| 任丘市| 桂阳县| 中卫市| 金乡县| 同江市| 奉节县| 西贡区| 克山县| 米泉市| 龙江县| 静海县| 吉林市| 龙川县| 曲松县| 阜新| 措勤县| 灵川县| 英山县| 凯里市| 三亚市| 金川县| 定结县| 桂平市| 金寨县| 白玉县| 九台市| 桂林市| 桐乡市| 马鞍山市|